Ameritas Investment Partners, Inc. Dyne Therapeutics, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 7,906 shares of DYN stock, worth $201,286. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,906
Previous 7,906
-0.0%
Holding current value
$201,286
Previous $279,000
1.43%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding DYN
# of Institutions
209Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$204 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$188 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$175 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$174 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$173 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.32B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...